Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms

The current study evaluated the effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and investigated its possible mechanisms. 124 patients were randomized to receive 25 mg empagliflozin QD, or placebo double blind for 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Lan, Fu, Qianyu, Zhou, Longhua, Fan, Yuqin, Liu, Fenfen, Fan, Yuanyuan, Zhang, Xin, Lin, Weiqing, Wu, Xiaohe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894447/
https://www.ncbi.nlm.nih.gov/pubmed/35241720
http://dx.doi.org/10.1038/s41598-022-07395-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894447/
https://www.ncbi.nlm.nih.gov/pubmed/35241720
http://dx.doi.org/10.1038/s41598-022-07395-x

Ejemplares similares